The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020)

M Egi, H Ogura, T Yatabe, K Atagi, S Inoue, T Iba… - Journal of intensive …, 2021 - Springer
Abstract The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic
Shock 2020 (J-SSCG 2020), a Japanese-specific set of clinical practice guidelines for sepsis …

ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients

A Alanio, PM Hauser, K Lagrou… - Journal of …, 2016 - academic.oup.com
Abstract The Fifth European Conference on Infections in Leukaemia (ECIL-5) convened a
meeting to establish evidence-based recommendations for using tests to diagnose …

Coronavirus disease 2019–associated invasive fungal infection

JW Baddley, GR Thompson III… - Open forum …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …

Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective Study

J Jiang, L Bai, W Yang, W Peng, J An, Y Wu… - Infectious Diseases and …, 2021 - Springer
Introduction This study aimed to evaluate the utility of metagenomic next-generation
sequencing (mNGS) for the diagnosis of Pneumocystis jirovecii pneumonia (PJP) in non …

The mycobiome in health and disease: emerging concepts, methodologies and challenges

PY Tiew, M Mac Aogain, NABM Ali, KX Thng, K Goh… - Mycopathologia, 2020 - Springer
Fungal disease is an increasingly recognised global clinical challenge associated with high
mortality. Early diagnosis of fungal infection remains problematic due to the poor sensitivity …

Pneumocystis jirovecii: a review with a focus on prevention and treatment

RB Weyant, D Kabbani, K Doucette, C Lau… - Expert opinion on …, 2021 - Taylor & Francis
Introduction: Pneumocystis jirovecii (PJ) is an opportunistic fungal pathogen that can cause
severe pneumonia in immunocompromised hosts. Risk factors for Pneumocystis jirovecii …

Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease

M Hoenigl, A Arastehfar, MC Arendrup… - Clinical Microbiology …, 2024 - Am Soc Microbiol
Fungal infections are on the rise, driven by a growing population at risk and climate change.
Currently available antifungals include only five classes, and their utility and efficacy in …

Pneumocystis pneumonia in the twenty-first century: HIV-infected versus HIV-uninfected patients

C Cillóniz, C Dominedò… - Expert Review of Anti …, 2019 - Taylor & Francis
ABSTRACT Introduction: Pneumocystis pneumonia (PcP) has classically been described as
a serious complication in patients infected with the human immunodeficiency virus (HIV) …

[HTML][HTML] Febrile neutropenia in acute leukemia. Epidemiology, etiology, pathophysiology and treatment

BA Hansen, Ø Wendelbo, Ø Bruserud… - … journal of hematology …, 2020 - ncbi.nlm.nih.gov
Acute leukemias are a group of aggressive malignant diseases associated with a high
degree of morbidity and mortality. An important cause of both the latter is infectious …

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients

C Cordonnier, S Cesaro, G Maschmeyer… - Journal of …, 2016 - academic.oup.com
Pneumocystis jirovecii can cause life-threatening pneumonia following treatment for
haematological malignancies or after HSCT. The mortality rate of P. jirovecii pneumonia …